Compare SoFi Technologies Inc (SOFI) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SoFi Technologies Inc vs GeneDx Holdings Corp — how do they compare? SoFi Technologies Inc trades at $17.35 (market cap $23.26B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). The key difference: SoFi Technologies Inc is far larger — about 9.1× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals.
| SOFI | WGS | |
|---|---|---|
Market Cap | $23.26B | $2.56B |
Sector | Financials | Technology |
52-Week High | $32.21 | $167.51 |
52-Week Low | $15.15 | $34.51 |
Enterprise Value | — | $2.60B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SoFi Technologies trades at $18.01, down 1.15% amid mixed signals. The stock shows strong fundamental progress with 40% revenue growth and three consecutive earnings beats, though Q3 2026 expectations of $0.17 EPS present a high bar. Technical indicators are neutral with support at $18 and resistance at $19. Recent partnership with Payward expands banking infrastructure capabilities while rising Treasury yields pressure fintech lenders.
SoFi presents a growth story with expanding profitability and strategic partnerships, though negative operating cash flow and high valuation multiples warrant caution. Analyst consensus targets $20.78 with 37% buy ratings, suggesting moderate upside potential balanced against macroeconomic sensitivity and competitive pressures in the digital banking space.
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
